FDA approves Mylan's generic version of Depakote

03/14/2007 | Forbes

Mylan Laboratories said the FDA granted tentative approval for its generic version of Abbott Laboratories' Depakote. The drug is for treating migraine headaches, epileptic disorders and manic episodes associated with bipolar disorder.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN